TEVETEN

This brand name is authorized in Austria, Australia, Canada, Cyprus, Germany, Ecuador, Estonia, Finland, Hong Kong, Ireland, Lithuania, Malta, Netherlands, Poland, Singapore, Turkey, United Kingdom, South Africa

Active ingredients

The drug TEVETEN contains one active pharmaceutical ingredient (API):

1 Eprosartan UNII 8N2L1NX8S3 - EPROSARTAN MESYLATE

Eprosartan is a potent, synthetic, orally active non-biphenyl non-tetrazole angiotensin II receptor antagonist, which binds selectively to the AT1 receptor. Read about Eprosartan

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C09CA02	Eprosartan	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09C Angiotensin II antagonists, plain → C09CA Angiotensin II antagonists, plain
Discover more medicines within C09CA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 5491B, 8397Y, 8447N, 8951D
Country: CA	Health Products and Food Branch	Identifier(s): 02240432, 02243942
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00577426, 00754532, 02585140, 11010390
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 3175-MEE-0318
Country: EE	Ravimiamet	Identifier(s): 1010855, 1081101, 1081112, 1888140
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 000449
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 13975, 139918, 146636, 146639, 146643, 162733, 21711
Country: HK	Department of Health Drug Office	Identifier(s): 48755
Country: IE	Health Products Regulatory Authority	Identifier(s): 49420, 49422, 49468, 49480
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1004295, 1006743, 1006744
Country: MT	Medicines Authority	Identifier(s): MA1507/02101
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 48135, 54887
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100100885
Country: SG	Health Sciences Authority	Identifier(s): 11807P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699820090173
Country: ZA	Health Products Regulatory Authority	Identifier(s): 35/7.1/0372